Anixa Biosciences' breast cancer vaccine elicited targeted immune responses in 70% of patients. Click here to read an ...

CRISPR Therapeutics is revolutionizing medicine with gene editing. Learn more about CRSP's breakthroughs, stock rally, and ...

Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to ...

The Damon Runyon Cancer Research Foundation has named five new Damon Runyon Clinical Investigators. The recipients of this prestigious award are outstanding, early-career physician-scientists ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85% ...

Hepatitis B is relatively frequent in the Bouaké military region, with a prevalence of 5.23%. It predominantly affects ...

The Foundation also awarded Continuation Grants to three Damon Runyon Clinical Investigators, totaling $1,000,000 in additional funding. The Continuation Grants are designed to support Clinical ...

If I have sounded like a broken record these past months, it is because these developments in American public health are as ...

In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...

Fund announced today a total investment of approximately JPY 1 billion (USD 7.3 million1) in four R&D projects for the development of vaccine, drug, and diagnostics for malaria and tuberculosis (TB).2 ...

A new study done by scientists in Switzerland and Sweden investigated the use of automated systems to develop multispecific antibodies.

In a routine blood test that turned extraordinary, French scientists have identified the world’s newest and rarest blood group. The sole known carrier is a woman from Guadeloupe whose blood is so ...